newsfilter
← Latest News
PR Newswire·

Northwest Biotherapeutics Announces Approval of Pediatric Investigation Plan (PIP) by MHRA

PIP Approval Is A Pre-Requisite for Application for Approval of A New Medicine for Adult Patients BETHESDA, Md., Aug. 23, 2022 /PRNewswire/ -- Northwest Biotherapeutics (OTCQB:NWBO) ("NW Bio"), a biotechnology company developing DCVax® personalized